Author: Kim, Chang Hyeun; Lee, Sang Weon; Kim, Young Ha; Sung, Soon Ki; Son, Dong Wuk; Song, Geun Sung
Title: Predictors of Hematoma Enlargement in Patients with Spontaneous Intracerebral Hemorrhage Treated with Rapid Administration of Antifibrinolytic Agents and Strict Conservative Management Document date: 2019_9_11
ID: 5vklxexq_13
Snippet: Tranexamic acid was applied according to the protocol in 67 of 329 patients. TABLE 1 shows the characteristics of patients who did and did not receive tranexamic acid. There was no statistically significant difference between the 2 groups in mean age, sex, size and volume of hematoma, spot signs on hematomas, BP, medical history (hypertension, diabetes mellitus, dyslipidemia, cardiovascular disease, stroke, alcohol), and drug use (antiplatelet or.....
Document: Tranexamic acid was applied according to the protocol in 67 of 329 patients. TABLE 1 shows the characteristics of patients who did and did not receive tranexamic acid. There was no statistically significant difference between the 2 groups in mean age, sex, size and volume of hematoma, spot signs on hematomas, BP, medical history (hypertension, diabetes mellitus, dyslipidemia, cardiovascular disease, stroke, alcohol), and drug use (antiplatelet or anticoagulant), except smoking status and CKD.
Search related documents:
Co phrase search for related documents- anticoagulant antiplatelet and cardiovascular disease: 1, 2, 3, 4
- anticoagulant antiplatelet and mean age: 1, 2, 3, 4, 5, 6, 7, 8
- anticoagulant antiplatelet and spot sign: 1
- anticoagulant antiplatelet and statistically significant difference: 1, 2
- cardiovascular disease and CKD status: 1, 2, 3, 4
- cardiovascular disease and mean age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- cardiovascular disease and medical history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
- cardiovascular disease and statistically significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9
- cardiovascular disease and volume size: 1
- CKD status and mean age: 1, 2, 3, 4
- CKD status and medical history: 1, 2
- mean age and medical history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- mean age and statistically significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- mean age and volume size: 1, 2
- medical history and statistically significant difference: 1, 2, 3
- medical history and tranexamic acid: 1, 2
- spot sign and statistically significant difference: 1
- spot sign and tranexamic acid: 1, 2, 3
- spot sign and tranexamic acid receive: 1
Co phrase search for related documents, hyperlinks ordered by date